Surgical management of hepatocellular carcinoma: Resection and ablation

Journal of Vascular and Interventional Radiology

Volumn 13, Issue 9 II, 2002, Pages

  Choti, Michael A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Liver neoplasms, therapeutic radiology; Liver, surgery

Indexed keywords

ALCOHOL;

CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; ECHOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; MICROWAVE RADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL HEPATECTOMY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOFREQUENCY RADIATION; REVIEW; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0036741688     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1051-0443(07)61787-4     Document Type: Review

References (71)

1. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129:643-653.
2. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994; 219:236-247.
3. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218:145-151.
4. Gozzetti G, Mazziotti A, Grazi GL, et al. Surgical experience with 168 primary liver cell carcinomas treated with hepatic resection. J Surg Oncol Suppl 1993; 3:59-61.
5. Segawa T, Tsuchiya R, Furui J, Izawa K, Tsunoda T, Kanematsu T. Operative results in 143 patients with hepatocellular carcinoma. World J Surg 1993; 17:663-667.
6. Tang ZY, Yu YQ, Zhou XD. Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s. Semin Surg Oncol 1993; 9:293-297.
7. Kakazu T, Makuuchi M, Kawasaki S, et al. Repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 1993; 40:337-341.
8. Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocellular carcinoma: results of 229 consecutive patients during 11 years. Ann Surg 1993; 217:375-384.
9. Takenaka K, Kawahara N, Yamamoto K, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 131:71-76.
10. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 1998; 82:1028-1036.
11. Fan ST, Ng IO, Poon RT, Lo CM, Liu CL, Wong J. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg 1999; 134:1124-1130.
12. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229:790-799.
13. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical rereatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434-1440.
14. Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery 2002 131(suppl 1):S153-158.
15. Fuster J, Garcia-Valdecasas JC, Grande L, et al. Hepatocellular carcinoma and cirrhosis: results of surgical treatment in a European series. Ann Surg 1996; 223:297-302.
16. Tani M, Edamoto Y, Kawai S, Kobori O, Hayashi S, Hanada K. Results of 90 consecutive hepatectomies for hepatocellular carcinoma: a multivariate analysis of survival. Semin Oncol 1997; 24(2 suppl 6):S6.
17. Choti MA, Bowman HM, Pitt HA, et al. Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg 1998; 2:11-20.
18. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999; 229:210-215.
19. Lee CS, Sheu JC, Wang M, Hsu HC. Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg 1996; 83:330-333.
20. Vauthey JN, Klimstra D, Franceschi D, et al. Factors-affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169:28-34
21. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235:373-382.
22. The Liver Cancer Study Group of Japan. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74:2772-2780.
23. Malt RA. Surgery for hepatic neoplasms. N Engl J Med 1985; 313:1591-1596.
24. Torzilli G, Minagawa M, Takayama T, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30:889-893.
25. Iwatsuki S, Starzl TE. Role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol 1993; 9:337-340.
26. Colella G, De Carlis L, Rondinara GF, et al. Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? Transpl Proc 1997; 29:492-494.
27. Figueras J, Garcia-Valdecasas JC, Rafecas A, et al. Prognosis of hepatocarcinoma in liver transplantation in cirrhotic patients. Transpl Proc 1997; 29:495.
28. Loinaz C, Gomez R, Gonzalez-Pinto I, et al. A decade of liver transplantation in primary liver tumors. Transpl Proc 1998; 30:3296-3297.
29. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228:479-490.
30. Neuhaus P, Jonas S, Bechstein WO, et al. Liver transplantation for hepatocellular carcinoma. Transpl Proc 1999; 31:469-471.
31. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
32. Brown RS Jr, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002; 8:278-284.
33. Stone MJ, Klintmalm GB, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 1993; 104:196-202.
34. Cherqui D, Piedbois P, Pierga JY, et al. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma: a pilot study. Cancer 1994; 73:2721-2726.
35. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226:688-701.
36. Oldhafer KJ, Chavan A, Fruhauf NR, et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 1998; 29:953-959.
37. Lai EC, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1998; 133:183-188.
38. Sciarrino E, Simonetti RG, Le Moli S, Pagliaro L. Adriamycin treatment for hepatocellular carcinoma: experience with 109 patients. Cancer 1985; 56:2751-2755.
39. Chlebowski RT, Brzechwa-Adjukiewicz A, Cowden A, Block JB, Tong M, Chan KK. Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. Cancer Treat Rep 1984; 68:487-491.
40. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'eng FK. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995; 82:122-126.
41. Izumi R, Shimizu K, Iyobe T, et al. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20:295-301.
42. Lygidakis NJ, Pothoulakis J, Konstantinidou AE, Spanos H. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy: a prospective randomized study. Anticancer Res 1995; 15:543-550.
43. Muto Y, Moriwaki H, Ninomiya M, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334:1561-1567.
44. Leung WT, Lau WY, Ho S, et al. Reduction of local recurrence after adjuvant intra-arterial lipiodol-iodine-131 for hepatocellular carcinoma: a planned interim analysis of a prospective randomized study (abstr). Proc Am Soc Clin Oncol 1997; 16:279.
45. Kotoh K, Sakai H, Sakamoto S, et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 1994; 89:194-198.
46. Livraghi T, Lazzaroni S, Meloni F, Torzilli G, Vettori C. Intralesional ethanol in the treatment of unresectable liver cancer. World J Surg 1995; 19:801-806.
47. Okuda K. Intratumor ethanol injection. J Surg Oncol Suppl 1993; 3:97-99.
48. Lencioni R, Bartolozzi C, Caramella D, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 1995; 76:1737-1746.
49. Livraghi T, Lazzaroni S, Pellicano S, Ravasi S, Torzilli G, Vettori C. Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia. AJR Am J Roentgenol 1993; 161:1065-1069.
50. Lezoche E, Paganini AM, Feliciotti F, Guerrieri M, Lugnani F, Tamburini A. Ultrasound-guided laparoscopic cryoablation of hepatic tumors: preliminary report. World J Surg 1998; 22:829-835.
51. Huang A, McCall JM, Weston MD, et al. Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br J Surg 2002; 89:303-310.
52. Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Surg 1997; 173:358-365.
53. Zhou XD, Tang ZY, Yu YQ, et al. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases. J Cancer Res Clin Oncol 1993; 120:100-102.
54. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radio-frequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9:101-111.
55. Bowles BJ, Machi J, Limm WM, et al. Safety and efficacy of radio-frequency thermal ablation in advanced liver tumors. Arch Surg 2001; 136:864-869.
56. Dominique E, El Otmany A, Goharin A, Attalah D, de Baere T. Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation. J Surg Oncol 2001; 76:297-300.
57. Siperstein A, Garland A, Engle K, et al. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors: technical considerations. Surg Endosc 2000; 14:400-405.
58. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radio-frequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227:559-565.
59. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000; 88:2452-2463.
60. Chinn SB, Lee FTJ, Kennedy GD, et al. Effect of vascular occlusion on radio-frequency ablation of the liver: results in a porcine model. AJR Am J Roentgenol 2001; 176:789-795.
61. de Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 2002; 178:53-59.
62. Livraghi T, Goldberg SN, Monti F, et al. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202:205-210.
63. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radio-frequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 2001; 26:345-360.
64. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661.
65. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167:759-768.
66. Curley SA, Izzo F, Delrio P, et al. Radio-frequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230:1-8.
67. Curley SA, Izzo F, Ellis LM, Nicolas VJ, Vallone P. Radio-frequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232:381-391.
68. Jiao LR, Hansen PD, Havlik R, Mitry RR, Pignatelli M, Habib N. Clinical short-term results of radio-frequency ablation in primary and secondary liver tumors. Am J Surg 1999; 177:303-306.
69. Murakami R, Yoshimatsu S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR Am J Roentgenol 1995; 164:1159-1164.
70. Yamanaka N, Tanaka T, Oriyama T, Furukawa K, Tanaka W, Okamoto E. Microwave coagulonecrotic therapy for hepatocellular carcinoma. World J Surg 1996; 20:1076-1081.
71. Tian JH, Xu BX, Zhang JM, Dong BW, Liang P, Wang XD. Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J Nucl Med 1996; 37:958-963.